Pandemic impact on pharma/clinical engagement U.S. 2020

According to a survey conducted in August-September 2020, 70 percent of provider executives said that the COVID-19 pandemic somewhat negatively impacted pharmaceuticals sales representatives engagement with clinicians. This statistic illustrates the impact of the COVID-19 pandemic on the engagement between U.S. pharmaceuticals sales representatives and clinicians.

Negative impact of COVID-19 on engagement between U.S. pharmaceuticals sales representatives and clinicians as of 2020

Characteristic	Very negatively	Somewhat negatively
Provider executives	7%	70%
Pharmaceutical and life sciences executives	4%	68%

Loading statistic...

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

Release date

December 2020

More information

Region

United States

Survey time period

August 21 to September 10, 2020

Number of respondents

153 provider, 124 pharmaceutical and life sciences executives

Method of interview

Online survey

Supplementary notes

Original question: "How negatively or positively has the COVID-19 pandemic affected engagement between pharmaceuticals sales representatives and clinicians?"

Citation formats